APIGENIN INCREASES CISPLATIN INHIBITORY EFFECTS ON THE TELOMERASE ACTIVITY OF TRIPLE NEGATIVE BREAST CANCER CELLS. JT. 2017;80(1). doi:10.11113/jt.v80.10378